Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

SHE:002932 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	352.69	493.91	1,016	2,556	1,190	669.11
Short-Term Investments	2,808	738.79	-	70	-	-
Trading Asset Securities	64.12	64.12	122.59	1,953	700	200
Cash & Short-Term Investments	3,224	1,297	1,138	4,578	1,890	869.11
Cash Growth	190.89%	13.93%	-75.14%	142.22%	117.48%	134.57%
Accounts Receivable	714.29	766.95	1,254	2,736	740.42	185.03
Other Receivables	11.49	80.52	70.28	17.52	11.97	5.46
Receivables	725.77	847.47	1,324	2,754	752.39	190.49
Inventory	76.06	82.3	128.77	258.44	284.59	117.73
Other Current Assets	280.71	171.08	158.83	91.09	72.98	40.77
Total Current Assets	4,307	2,398	2,750	7,682	3,000	1,218
Property, Plant & Equipment	736.36	721.68	543.6	521.59	243.47	123.26
Long-Term Investments	316.11	257.61	156.36	83.49	60.62	46.4
Other Intangible Assets	17.07	17.3	17.7	21.24	16.59	16.93
Long-Term Deferred Tax Assets	214.68	216.9	210.18	173.95	16.63	7.6
Long-Term Deferred Charges	2.83	3.11	14.87	17.21	1.45	1.74
Other Long-Term Assets	905.43	2,979	3,694	695.33	78.24	12.61
Total Assets	6,499	6,593	7,387	9,195	3,417	1,427
Accounts Payable	248.24	278.11	681.58	1,294	174.31	30.94
Accrued Expenses	70.18	87.97	154.94	364.68	83.18	29.78
Short-Term Debt	3	3	23.61	164.67	30	141.5
Current Portion of Leases	4.3	4.3	7.29	18.17	3.62	-
Current Income Taxes Payable	5.17	6.44	6.27	144.02	131.8	24.58
Current Unearned Revenue	40.05	37.96	53.17	309.58	71.18	27.74
Other Current Liabilities	50.54	78.07	92.5	69.96	51.9	54.87
Total Current Liabilities	421.48	495.86	1,019	2,365	545.98	309.42
Long-Term Leases	5.53	5.82	18.25	20.75	10.74	-
Long-Term Unearned Revenue	20.87	20.87	14.26	5.96	5.96	0.02
Long-Term Deferred Tax Liabilities	50.42	50.42	39.59	31.07	4.33	2.32
Other Long-Term Liabilities	1.44	1.44	3.03	-	-	-
Total Liabilities	499.73	574.4	1,094	2,423	567.02	311.77
Common Stock	232.52	232.52	232.52	156.19	104.88	69.01
Additional Paid-In Capital	818.1	818.1	820.18	887.89	904.5	400.24
Retained Earnings	5,004	5,014	4,973	5,472	1,812	681.94
Treasury Stock	-247.96	-237.95	-	-16.02	-32.77	-49.39
Total Common Equity	5,807	5,826	6,026	6,500	2,789	1,102
Minority Interest	192.54	192.29	266.21	271.92	61.25	13.09
Shareholders' Equity	6,000	6,019	6,292	6,772	2,850	1,115
Total Liabilities & Equity	6,499	6,593	7,387	9,195	3,417	1,427
Total Debt	12.82	13.11	49.16	203.59	44.36	141.5
Net Cash (Debt)	3,212	1,284	1,089	4,375	1,846	727.61
Net Cash Growth	197.50%	17.87%	-75.10%	137.02%	153.67%	96.38%
Net Cash Per Share	14.98	5.68	4.80	19.03	8.72	3.49
Filing Date Shares Outstanding	219.49	220.05	232.52	232.73	232.84	214.48
Total Common Shares Outstanding	219.49	220.05	232.52	232.73	232.84	214.48
Working Capital	3,885	1,902	1,731	5,317	2,454	908.68
Book Value Per Share	26.46	26.48	25.92	27.93	11.98	5.14
Tangible Book Value	5,790	5,809	6,008	6,479	2,772	1,085
Tangible Book Value Per Share	26.38	26.40	25.84	27.84	11.91	5.06
Buildings	-	440.3	116.98	116.66	78	51.08
Machinery	-	380.8	402.91	374.05	158.18	113.44
Construction In Progress	-	120.79	185.19	121.52	73.58	19.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.